China Intravenous Infusion Pumps Market Size & Outlook

The intravenous infusion pumps market in China is expected to reach a projected revenue of US$ 534.7 million by 2030. A compound annual growth rate of 9.2% is expected of China intravenous infusion pumps market from 2024 to 2030.
Revenue, 2023 (US$M)
$288.1
Forecast, 2030 (US$M)
$534.7
CAGR, 2024 - 2030
9.2%
Report Coverage
China

China intravenous infusion pumps market, 2018-2030 (US$M)

China

Related Markets

China intravenous infusion pumps market highlights

  • The China intravenous infusion pumps market generated a revenue of USD 288.1 million in 2023 and is expected to reach USD 534.7 million by 2030.
  • The China market is expected to grow at a CAGR of 9.2% from 2024 to 2030.
  • In terms of segment, volumetric infusion pumps was the largest revenue generating product in 2023.
  • Insulin Infusion Pumps is the most lucrative product segment registering the fastest growth during the forecast period.


Intravenous infusion pumps market data book summary

Market revenue in 2023USD 288.1 million
Market revenue in 2030USD 534.7 million
Growth rate9.2% (CAGR from 2023 to 2030)
Largest segmentVolumetric infusion pumps
Fastest growing segmentInsulin Infusion Pumps
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationVolumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps
Key market players worldwideBaxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International


Other key industry trends

  • In terms of revenue, China accounted for 5.0% of the global intravenous infusion pumps market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China intravenous infusion pumps market is projected to lead the regional market in terms of revenue in 2030.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 454.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intravenous Infusion Pumps Market Scope

Intravenous infusion pumps market segmentation & scope
Volumetric Infusion Pumps
Syringe Infusion Pumps
Insulin Infusion Pumps
Enteral Infusion Pumps
Ambulatory Infusion Pumps
Patient-Controlled Analgesia Infusion Pumps
Implantable Infusion Pumps
Other Infusion Pumps
Chemotherapy
Diabetes
Gastroenterology
Analgesia/Pain Management
Pediatrics/Neonatology
Hematology
Other Indications

Intravenous Infusion Pumps Market Companies

Name Profile # Employees HQ Website

China intravenous infusion pumps market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.


Volumetric infusion pumps was the largest segment with a revenue share of 16.83% in 2023. Horizon Databook has segmented the China intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.


China is one of the more favorable emerging markets in the world, mainly because of its large population, low cost of manufacturing, and strong R&D. China’s population is aging, and, like many countries, its major disease burden is chronic illnesses. 

According to WHO, approximately 80% of deaths in China are due to chronic illnesses, including cardiovascular disease, stroke, cancer, COPD, and diabetes. This epidemiological transition has aided the growth of the country’s intravenous infusion pumps market. 

Behavioral factors such as unhealthy diets, physical inactivity, smoking, and increased stress have boosted the prevalence of chronic diseases. Factors such as technological advancements are playing a major role in growth of the infusion pumps market. 

Reasons to subscribe to China intravenous infusion pumps market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China intravenous infusion pumps market databook

  • Our clientele includes a mix of intravenous infusion pumps market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into China intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China intravenous infusion pumps market size, by product, 2018-2030 (US$M)

China Intravenous Infusion Pumps Market Outlook Share, 2023 & 2030 (US$M)

China intravenous infusion pumps market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more